JPS5041859A - - Google Patents

Info

Publication number
JPS5041859A
JPS5041859A JP49085967A JP8596774A JPS5041859A JP S5041859 A JPS5041859 A JP S5041859A JP 49085967 A JP49085967 A JP 49085967A JP 8596774 A JP8596774 A JP 8596774A JP S5041859 A JPS5041859 A JP S5041859A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP49085967A
Other versions
JPS5761035B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5041859A publication Critical patent/JPS5041859A/ja
Publication of JPS5761035B2 publication Critical patent/JPS5761035B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP49085967A 1973-08-01 1974-07-26 Expired JPS5761035B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US384666A US3883546A (en) 1973-08-01 1973-08-01 S-heterocyclic derivatives of phosphine or phosphite gold mercaptides

Publications (2)

Publication Number Publication Date
JPS5041859A true JPS5041859A (ja) 1975-04-16
JPS5761035B2 JPS5761035B2 (ja) 1982-12-22

Family

ID=23518252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49085967A Expired JPS5761035B2 (ja) 1973-08-01 1974-07-26

Country Status (9)

Country Link
US (1) US3883546A (ja)
JP (1) JPS5761035B2 (ja)
BE (1) BE818218A (ja)
CA (1) CA1054609A (ja)
DE (1) DE2437147C2 (ja)
FR (1) FR2240014B1 (ja)
GB (1) GB1422899A (ja)
SE (1) SE7409800L (ja)
ZA (1) ZA744598B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017519817A (ja) * 2014-05-28 2017-07-20 オースフェリクス・リミテッドＡｕｓｐｈｅｒｉｘ Ｌｉｍｉｔｅｄ 抗菌薬としての金（ｉ）−ホスフィン化合物
JP2017529357A (ja) * 2014-05-28 2017-10-05 オースフェリクス・リミテッドＡｕｓｐｈｅｒｉｘ Ｌｉｍｉｔｅｄ 抗菌薬としての金（ｉ）−ホスフィン化合物

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165380A (en) * 1977-02-25 1979-08-21 Smithkline Corporation Bis(sulfide)gold(1+) salts
US4172833A (en) * 1978-03-20 1979-10-30 R. T. Vanderbilt Company, Inc. Process for preparation of 2-mercaptotoluimidazole and salts thereof
WO1985000747A1 (en) * 1983-08-10 1985-02-28 Stockel Richard F Use of selenium-containing compounds for negating the toxic effects of gold compounds used in the treatment of rheumatoid arthritis, and a novel selenium-containing gold compound and use thereof as an anti-rheumatoid arthritis medicine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131206C (ja) * 1965-09-03
US3755329A (en) * 1970-12-22 1973-08-28 Du Pont Nitrogen-heterocyclylgold(i) compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017519817A (ja) * 2014-05-28 2017-07-20 オースフェリクス・リミテッドＡｕｓｐｈｅｒｉｘ Ｌｉｍｉｔｅｄ 抗菌薬としての金（ｉ）−ホスフィン化合物
JP2017529357A (ja) * 2014-05-28 2017-10-05 オースフェリクス・リミテッドＡｕｓｐｈｅｒｉｘ Ｌｉｍｉｔｅｄ 抗菌薬としての金（ｉ）−ホスフィン化合物

Also Published As

Publication number Publication date
BE818218A (fr) 1975-01-29
US3883546A (en) 1975-05-13
CA1054609A (en) 1979-05-15
JPS5761035B2 (ja) 1982-12-22
SE7409800L (ja) 1975-02-03
FR2240014A1 (ja) 1975-03-07
GB1422899A (en) 1976-01-28
AU7180774A (en) 1976-02-05
FR2240014B1 (ja) 1978-07-21
DE2437147C2 (de) 1983-03-03
DE2437147A1 (de) 1975-02-13
ZA744598B (en) 1975-07-30

Similar Documents

Publication Publication Date Title
AR201758A1 (ja)
AR201235Q (ja)
AR201231Q (ja)
AU450229B2 (ja)
AR201229Q (ja)
FR2240014B1 (ja)
AR199451A1 (ja)
AU480131B2 (ja)
AU477823B2 (ja)
AR210729A1 (ja)
AR200256A1 (ja)
AR200885A1 (ja)
AR196382A1 (ja)
AR197627A1 (ja)
AU447540B2 (ja)
AR201432A1 (ja)
AU461342B2 (ja)
AU477824B2 (ja)
AR196212Q (ja)
AU5288673A (ja)
AU1891376A (ja)
AU480080A (ja)
CH559615A5 (ja)
AU479539A (ja)
AU479522A (ja)